Crowd sentiment on LFVN · 30d

Method · 0 mentions

Bullish 0%

Neutral 100%

Bearish 0%

Across 0 classified mentions in the last 30 days, crowd sentiment for LFVN sits roughly neutral, with 0% reading bullish against 0% bearish across the classified sample.

LFVN insider trades

SEC Form 4

Date Insider Type Shares Value

02 Mar 2026 Dayton Judd Director BUY 10,500 $48K

27 Feb 2026 Dayton Judd Director BUY 18,097 $84K

26 Feb 2026 Dayton Judd Director BUY 4,600 $21K

09 Feb 2026 Lewis Darwin Director BUY 3,955 $21K

01 Jan 2026 Aure Carl Chief Financial Officer TAX WITHHOLD 1,527 $9K

01 Jan 2026 Cunningham Kristen Chief Sales Officer TAX WITHHOLD 1,926 $12K

01 Jan 2026 Fife Steven R President and CEO TAX WITHHOLD 9,169 $56K

01 Jan 2026 Neufeld Alissa General Counsel TAX WITHHOLD 1,445 $9K

LFVN earnings

SEC EDGAR

Date Period EPS Revenue

31 Mar 2026 Q3 2026 $0.11 —

31 Dec 2025 Q2 2026 $0.02 —

30 Sep 2025 Q1 2026 $0.17 —

30 Jun 2025 FY 2025 $0.75 —

Reported figures & scheduled dates · SEC EDGAR filings

About LifeVantage Corporation

LifeVantage Corporation develops, formulates, and sells nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The company distributes its products through a direct sales model using independent consultants in multiple countries, including the United States, Japan, Australia, and several others. Its product lines include Protandim, LifeVantage, PhysIQ, TrueScience, Petandim, and AXIO. LifeVantage was incorporated in Colorado in 1988 and reincorporated in Delaware in 2018.

Company

CEO Mr. Michael A. Beindorff

Founded 2003

Employees 232

Headquarters Lehi, UT, United States

Exchange NasdaqCM

Sector Consumer Defensive

Class Equity

Mentions · 30d 0

Classified base n=0

Website lifevantage.com

Most-discussed this week

GOOGL Alphabet SPCX Space Exploration Technologies Corp. MSFT Microsoft NFLX Netflix